Oxford Covid-19 vaccine doses improve immune response in animals

The ChAdOx1 nCoV-19 vaccine candidate is currently in Phase I clinical trial. Credit: Stig Alenas/Shutterstock.com



  • Oxford Covid-19 Vaccine